Hi all - it's been a while since I posted. In the interest of disclosure I just want to mention I sold most of my FGEN. I've just been getting a bit more concerned about off target tox since this article came out:
This also should be put into context of glaxo's comments that they like their drug vs competitors in part because they don't affect collagen prolyl hydroxylases, which they think could have direct cardiac effects.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.